eISSN: 1897-4309
ISSN: 1428-2526
Contemporary Oncology/Współczesna Onkologia
Current issue Archive Manuscripts accepted About the journal Supplements Addendum Special Issues Editorial board Reviewers Abstracting and indexing Subscription Contact Instructions for authors Publication charge Ethical standards and procedures
Editorial System
Submit your Manuscript
SCImago Journal & Country Rank
8/2006
vol. 10
 
Share:
Share:
abstract:

Importance of soluble cytokine receptors for inflammation associated cancer

Stefan Rose-John

Współcz Onkol (2006) vol. 10; 8 (378–384)
Online publish date: 2006/10/16
View full text Get citation
 
Cytokine receptors, which exist in membrane-bound and soluble form, bind their ligands with comparable affinity. While most soluble receptors are antagonists in that they compete for the ligands with their membrane counterparts, some soluble receptors are agonists. In this case, the complex of ligand and soluble receptor binds on target cells to a second receptor subunit and initiates signal transduction. The soluble receptors of the IL-6 family of cytokines (sIL-6R, sIL-11R, sCNTF-R) are agonists. In vivo, the IL-6/soluble IL-6R complex stimulates several types of target cells not stimulated by IL-6 alone, since they do not express membrane-bound IL-6R. This process has been named transsignalling. We have shown that in several chronic inflammatory diseases such as chronic inflammatory bowl disease, peritonitis and rheumatoid arthritis, transsignalling via soluble IL-6R complexed to IL-6 is a crucial point in the transition from the acute to the chronic state of the disease. The mechanism by which the IL-6/ soluble IL-6R complex regulates the inflammatory state is discussed.
keywords:

cytokine, cytokine receptor, soluble receptor, inflammation, gp130, sgp130Fc fusion protein

Quick links
© 2024 Termedia Sp. z o.o.
Developed by Bentus.